Literature DB >> 27020821

Ninety-day readmission after colorectal cancer surgery in a Veterans Affairs cohort.

Sonia T Orcutt1, Linda T Li2, Courtney J Balentine2, Daniel Albo2, Samir S Awad3, David H Berger3, Daniel A Anaya4.   

Abstract

BACKGROUND: Readmissions following colorectal surgery are common. However, there are limited data examining unplanned readmissions (URs) after colorectal cancer (CRC) surgery. The goal of this study was to identify reasons and predictors of UR, and to examine their clinical impact on CRC patients.
METHODS: A retrospective cohort study using a prospective CRC surgery database of patients treated at a VA tertiary referral center was performed (2005-2011). Ninety-day URs were recorded and classified based on reason for readmission. Clinical impact of UR was measured using a validated classification for postoperative complications. Multivariate logistic regression analyses were performed to identify predictors of UR.
RESULTS: 487 patients were included; 104 (21%) required UR. Although the majority of UR were due to surgical reasons (n = 72, 69%), medical complications contributed to 25% of all readmission events. Nearly half of UR (n = 44, 40%) had significant clinical implications requiring invasive interventions, intensive care unit stays, or led to death. After multivariate logistic regression, the following independent predictors of UR were identified: African-American race (odds ratio [OR] 0.47 [0.27-0.88]), ostomy creation (OR 2.50 [1.33-4.70]), and any postoperative complication (OR 4.36 [2.48-7.68]).
CONCLUSIONS: Ninety-day URs following colorectal cancer surgery are common, and represent serious events associated with worse outcomes. In addition to postoperative complications, surgical details that can be anticipated (i.e., ileostomy creation) and medical events unrelated to surgery, both contribute as important and potentially preventable reasons for UR. Future studies should focus on developing and examining interventions focused at improving the process of perioperative care for this high-risk population.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer surgery; Health care delivery; Hospital readmissions; Outcomes research

Mesh:

Year:  2015        PMID: 27020821     DOI: 10.1016/j.jss.2015.11.026

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

Review 1.  Health Care Policy and Outcomes after Colon and Rectal Surgery: What Is the Bigger Picture?-Cost Containment, Incentivizing Value, Transparency, and Centers of Excellence.

Authors:  Anuradha R Bhama; Stefan D Holubar; Conor P Delaney
Journal:  Clin Colon Rectal Surg       Date:  2019-04-02

2.  Fitbit step counts during inpatient recovery from cancer surgery as a predictor of readmission.

Authors:  Carissa A Low; Dana H Bovbjerg; Steven Ahrendt; M Haroon Choudry; Matthew Holtzman; Heather L Jones; James F Pingpank; Lekshmi Ramalingam; Herbert J Zeh; Amer H Zureikat; David L Bartlett
Journal:  Ann Behav Med       Date:  2018-01-05

3.  Predicting the Risk of Readmission From Dehydration After Ileostomy Formation: The Dehydration Readmission After Ileostomy Prediction Score.

Authors:  Sophia Y Chen; Miloslawa Stem; Marcelo Cerullo; Joseph K Canner; Susan L Gearhart; Bashar Safar; Sandy H Fang; Jonathan E Efron
Journal:  Dis Colon Rectum       Date:  2018-12       Impact factor: 4.585

4.  Patient experience with discharge instructions in postdischarge recovery: a qualitative study.

Authors:  Molly J Horstman; Whitney L Mills; Levi I Herman; Cecilia Cai; George Shelton; Tareq Qdaisat; David H Berger; Aanand D Naik
Journal:  BMJ Open       Date:  2017-02-22       Impact factor: 2.692

5.  Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy.

Authors:  Xin Wu; Guole Lin; Huizhong Qiu; Yi Xiao; Bin Wu; Miner Zhong
Journal:  Eur J Med Res       Date:  2018-05-22       Impact factor: 2.175

6.  The 30-day hospital readmission and mortality after surgery in colorectal cancer patients.

Authors:  Mesnad S Alyabsi; Anwar H Alqarni; Latifah M Almutairi; Mohammed A Algarni; Kanan M Alshammari; Adel Almutairi; Nahar A Alselaim
Journal:  BMC Gastroenterol       Date:  2022-10-14       Impact factor: 2.847

7.  Liquid Chromatography-Mass Spectrometry-Based Plasma Metabolomics Study of the Effects of Moxibustion with Seed-Sized Moxa Cone on Hyperlipidemia.

Authors:  Qinghua Shao; Jie Cheng; Yi Li; Guangxia Ni
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-22       Impact factor: 2.629

8.  Differences in Cancer Care Expenditures and Utilization for Surgery by Hospital Type Among Patients With Private Insurance.

Authors:  Samuel U Takvorian; Laura Yasaitis; Manqing Liu; Daniel J Lee; Rachel M Werner; Justin E Bekelman
Journal:  JAMA Netw Open       Date:  2021-08-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.